Can an FDA-approved drug help halt vision loss in MS?
vision loss
OMRF discovery could lead to new therapies for MS
OMRF researchers found that, in laboratory mice, a particular white blood cell seems to play a key role in MS.
OMRF receives $2.25 million grant to study vision loss
OMRF scientist Scott Plafker has received a four-year grant from the NIH to study whether a natural compound can help prevent a common eye disease.
Trio of new grants brings $2.7 million to OMRF labs
Awards “a testament to the quality of research in Oklahoma”
